Status:
COMPLETED
Electronic Symptom Follow-up of Cancer Patients
Lead Sponsor:
Oulu University Hospital
Conditions:
Cancer
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Use of ePROs in oncological care have resulted in improvement of QoL, decreased ER visits, and improvement of overall survival. Furthermore, ePRO follow-up resulted in better QoL, improved ECOG status...
Eligibility Criteria
Inclusion
- Written informed consent prior to any study procedure
- Advanced breast, lung, colorectal, or pancreatic cancer
- New cancer medical treatment, chemotherapy or targeted therapy initiated within -/+ 2 weeks from signed consent
- Age ≥18y
- ECOG 0-2
- CRC cohort: Patients with adjuvant treatment, or first or second line of treatment for metastatic disease
- Patient compliant with study procedures
Exclusion
- Initiation of new cancer medical treatment \> 2 wks from signed consent
- Any medical condition that the Investigator considers significant to compromise the safety of the patient or that impairs the interpretation of study assessments
- No internet access/email
Key Trial Info
Start Date :
January 1 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 31 2022
Estimated Enrollment :
43 Patients enrolled
Trial Details
Trial ID
NCT04081558
Start Date
January 1 2018
End Date
May 31 2022
Last Update
August 29 2025
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Oulu University Hospital
Oulu, Finland
2
Vaasa Central Hospital
Vaasa, Finland